Conversational Agents for Chronic Disease Self-Management: A Systematic Review (Preprint)

2019 ◽  
Author(s):  
Ashley Clara Griffin ◽  
Zhaopeng Xing ◽  
Saif Khairat ◽  
Yue Wang ◽  
Stacy Bailey ◽  
...  

BACKGROUND Conversational agents have the potential to deliver patient-centered interventions that focus on goal setting, feedback, and education. However, little is known how these agents may be utilized to assist patients with chronic disease self-management. OBJECTIVE The objective of this study was to systematically review the literature to assess how conversational agents have been used to facilitate chronic disease self-management and to identify gaps in the evidence base. METHODS The systematic review utilized Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines across five databases. We included full-text journal articles or conference proceedings that contained primary research findings for text-based conversational agents focused on self-management for chronic diseases in adults. Two reviewers independently extracted information from the included studies, analyzed the data, grouped the studies into themes, and rated the quality of the studies. RESULTS 1,606 studies were identified, and 12 studies met inclusion criteria. There were five randomized controlled trials, five quasi-experimental studies, and two non-experimental studies. Studies were heterogeneous in design and many lacked methodological rigor. Participants mostly reported positive attitudes towards conversational agents, and there were improvements on the Patient Health Questionnaire (P<.05), Generalized Anxiety Disorder Scale (P=.004), Perceived Stress Scale (P=.048), Flourishing Scale (P=.032), and Overall Anxiety Severity and Impairment Scale (P<.05) between the conversational agent intervention and control groups in three randomized controlled trials. Major themes related to user perceptions were personalization, engagement, and social support. The majority of conversational agents were based upon theoretical grounding, but few studies reported using established design principles and no studies used heuristic evaluation. CONCLUSIONS Our findings suggest that conversational agents are acceptable and have the potential to support self-management particularly for mental health conditions. As this is an emerging area of research, efficacy of long-term use of conversational agents for chronic disease self-management is unknown but shows promise. Future studies should assess the characteristics of agents that may be most useful for self-management based on the patient’s clinical and sociodemographic characteristics, motivation, and preferences.

Nutrients ◽  
2019 ◽  
Vol 11 (10) ◽  
pp. 2520 ◽  
Author(s):  
Christine Tørris ◽  
Hilde Mobekk

Obesity and metabolic syndrome are considered major public health problems, and their negative impact on cardiovascular disease (CVD) and diabetes mellitus type 2 (DM2) is profound. Targeting modifiable risk factors such as dietary habits is therefore of great importance. Many of today’s health challenges with overweight and obesity may have behavioral roots, and traditional methods such as regulations and campaigns are often insufficient to improve dietary choices. Nudging or choice architecture might be a viable tool to influence people’s everyday choices and behaviors to better outcomes. This paper reviews the current state of the rapidly expanding number of experimental field studies that investigate the effects/associations of nudging on healthy food choices. A systematic literature search was conducted in PubMed, where 142 citations were identified. Based on selection criteria, six randomized controlled trials and 15 non-randomized controlled trials were ultimately included. The results of this systematic review show that many of the studies included traffic-light labeling, which may be a promising strategy. The reviewed findings, however, also highlight the challenges that confront experimental studies examining the impact of nudging on diet.


2020 ◽  
Vol 15 (3) ◽  
pp. 234-242 ◽  
Author(s):  
Eugenia Vlachou ◽  
Anastasia Ntikoudi ◽  
Ourania Govina ◽  
Maria Lavdaniti ◽  
Nikolaos Kotsalas ◽  
...  

Background: Diabetic Nephropathy is a frequent complication of diabetes mellitus due to functional and structural modifications in multiple kidney compartments. Probiotics have risen lately as a forthcoming therapeutic intervention but they have not been systematically evaluated in diabetic nephropathy so far. The aim of this systematic review was to evaluate randomized controlled trials and experimental studies assessing the effect of probiotic supplements on diabetic nephropathy. Methods: An extensive literature search was conducted through electronic databases (PubMed, Scopus, Cinahl and Medline) with the Medical Subject Headings and entry terms of “diabetic nephropathy”, “diabetic renal disease” and “probiotics”. The search yielded 116 results, 9 of which met the inclusion criteria for this systematic review. Results: Most of the microorganisms used in the studies belonged to the Lactobacillus and Bifidobacterium genus. The dosage ranged from 2×107 to 6×1010 CFU/ g. The form of the probiotics varied across the studies (capsules, sachets, soy milk, kefir and honey). The majority of the studies demonstrated the benefits of probiotic supplementation on the reduction of inflammation, oxidative stress and on the amelioration of renal function biomarkers in subjects with diabetic nephropathy. No major gastrointestinal adverse events were observed during the intervention time with probiotics. Conclusion: : Findings of this systematic review demonstrate the positive impact of probiotics on Diabetic Nephropathy without any major adverse events. Moreover, future larger randomized controlled trials with bigger samples and longer follow-up time are deemed necessary for further valid results on the effectiveness of probiotic supplementation on Diabetic Nephropathy.


Author(s):  
Yoo Jung Oh ◽  
Jingwen Zhang ◽  
Min-Lin Fang ◽  
Yoshimi Fukuoka

Abstract Background This systematic review aimed to evaluate AI chatbot characteristics, functions, and core conversational capacities and investigate whether AI chatbot interventions were effective in changing physical activity, healthy eating, weight management behaviors, and other related health outcomes. Methods In collaboration with a medical librarian, six electronic bibliographic databases (PubMed, EMBASE, ACM Digital Library, Web of Science, PsycINFO, and IEEE) were searched to identify relevant studies. Only randomized controlled trials or quasi-experimental studies were included. Studies were screened by two independent reviewers, and any discrepancy was resolved by a third reviewer. The National Institutes of Health quality assessment tools were used to assess risk of bias in individual studies. We applied the AI Chatbot Behavior Change Model to characterize components of chatbot interventions, including chatbot characteristics, persuasive and relational capacity, and evaluation of outcomes. Results The database search retrieved 1692 citations, and 9 studies met the inclusion criteria. Of the 9 studies, 4 were randomized controlled trials and 5 were quasi-experimental studies. Five out of the seven studies suggest chatbot interventions are promising strategies in increasing physical activity. In contrast, the number of studies focusing on changing diet and weight status was limited. Outcome assessments, however, were reported inconsistently across the studies. Eighty-nine and thirty-three percent of the studies specified a name and gender (i.e., woman) of the chatbot, respectively. Over half (56%) of the studies used a constrained chatbot (i.e., rule-based), while the remaining studies used unconstrained chatbots that resemble human-to-human communication. Conclusion Chatbots may improve physical activity, but we were not able to make definitive conclusions regarding the efficacy of chatbot interventions on physical activity, diet, and weight management/loss. Application of AI chatbots is an emerging field of research in lifestyle modification programs and is expected to grow exponentially. Thus, standardization of designing and reporting chatbot interventions is warranted in the near future. Systematic review registration International Prospective Register of Systematic Reviews (PROSPERO): CRD42020216761.


Sign in / Sign up

Export Citation Format

Share Document